Kang, J.H.; Lee, S.-H.; Lee, J.-S.; Oh, S.-J.; Ha, J.S.; Choi, H.-J.; Kim, S.-Y.
Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma. Cells 2020, 9, 1475.
https://doi.org/10.3390/cells9061475
AMA Style
Kang JH, Lee S-H, Lee J-S, Oh S-J, Ha JS, Choi H-J, Kim S-Y.
Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma. Cells. 2020; 9(6):1475.
https://doi.org/10.3390/cells9061475
Chicago/Turabian Style
Kang, Joon Hee, Seon-Hyeong Lee, Jae-Seon Lee, Su-Jin Oh, Ji Sun Ha, Hyun-Jung Choi, and Soo-Youl Kim.
2020. "Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma" Cells 9, no. 6: 1475.
https://doi.org/10.3390/cells9061475
APA Style
Kang, J. H., Lee, S.-H., Lee, J.-S., Oh, S.-J., Ha, J. S., Choi, H.-J., & Kim, S.-Y.
(2020). Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma. Cells, 9(6), 1475.
https://doi.org/10.3390/cells9061475